Robyn Karnauskas

Stock Analyst at Truist Securities

(2.43)
# 2,561
Out of 5,090 analysts
178
Total ratings
44.08%
Success rate
0.09%
Average return

Stocks Rated by Robyn Karnauskas

Eli Lilly and Company
Nov 19, 2025
Maintains: Buy
Price Target: $1,038$1,182
Current: $1,008.61
Upside: +17.19%
AbCellera Biologics
May 16, 2025
Maintains: Buy
Price Target: $28$10
Current: $3.56
Upside: +180.90%
Amgen
Jan 8, 2025
Maintains: Hold
Price Target: $333$298
Current: $332.52
Upside: -10.38%
Bristol-Myers Squibb Company
Jan 8, 2025
Maintains: Buy
Price Target: $62$65
Current: $52.37
Upside: +24.12%
Merck & Co.
Jan 8, 2025
Downgrades: Hold
Price Target: $130$110
Current: $100.07
Upside: +9.92%
Gilead Sciences
Aug 15, 2024
Maintains: Hold
Price Target: $82$83
Current: $121.38
Upside: -31.62%
AbbVie
Jul 26, 2024
Reiterates: Buy
Price Target: $195$210
Current: $226.54
Upside: -7.30%
Biomea Fusion
Jun 11, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.20
Upside: -
Biogen
May 16, 2024
Maintains: Buy
Price Target: $340
Current: $182.61
Upside: +86.19%
Curis
May 15, 2024
Maintains: Buy
Price Target: $26
Current: $1.36
Upside: +1,811.76%
Maintains: Buy
Price Target: $8$7
Current: $1.22
Upside: +476.13%
Maintains: Buy
Price Target: $1,135
Current: $722.63
Upside: +57.07%
Maintains: Buy
Price Target: $10
Current: $1.95
Upside: +414.14%
Maintains: Buy
Price Target: $9
Current: $3.54
Upside: +154.60%
Reiterates: Buy
Price Target: $23
Current: $21.10
Upside: +9.00%
Reiterates: Buy
Price Target: $48
Current: $22.66
Upside: +111.87%
Reiterates: Buy
Price Target: $50
Current: $25.40
Upside: +96.85%
Maintains: Buy
Price Target: $456$508
Current: $455.93
Upside: +11.42%
Maintains: Buy
Price Target: $42$36
Current: $25.99
Upside: +38.51%
Downgrades: Hold
Price Target: $25
Current: $77.37
Upside: -67.69%
Downgrades: Hold
Price Target: n/a
Current: $2.07
Upside: -
Reiterates: Buy
Price Target: $140
Current: $53.01
Upside: +164.10%
Reiterates: Buy
Price Target: $30,000
Current: $4.34
Upside: +691,144.24%
Reiterates: Hold
Price Target: $7
Current: $1.08
Upside: +548.15%
Maintains: Buy
Price Target: $65$55
Current: $20.77
Upside: +164.81%
Maintains: Buy
Price Target: $500$320
Current: $11.00
Upside: +2,810.41%
Maintains: Buy
Price Target: $10$15
Current: $24.37
Upside: -38.45%
Initiates: Buy
Price Target: $85
Current: $0.22
Upside: +38,536.36%